查詢結果分析
來源資料
相關文獻
- 狼瘡腎炎的治療概況
- Effective Treatment of Rapidly Deteriorated Renal Function with Methylprednisolone Pulse Therapy and High Dose Mycophenolate Mofetil in a Patient with Lupus Nephritis
- 狼瘡腎炎之用藥探討
- Acute Retinal Necrosis-Early Manifestation and Successful Treatment with Steroid and Acyclovir: Case Report
- 狼瘡腎炎之診斷與治療
- Eosinophilic Cystitis and Ureteritis after Radical Prostatectomy: Case Report and Literature Review
- 非類固醇類消炎藥--選擇性COX-2抑制劑
- 口腔外科與病理切片--病例報告
- 口服Ketorolac臨床安全性評估
- 口服Ketorolac藥物動力學特色
頁籤選單縮合
題 名 | 狼瘡腎炎的治療概況=Treatment of Lupus Nephritis |
---|---|
作 者 | 蔡敦仁; 高芷華; | 書刊名 | 內科學誌 |
卷 期 | 8:2 1997.06[民86.06] |
頁 次 | 頁62-69 |
分類號 | 415.74 |
關鍵詞 | 狼瘡腎炎; 病理切片; 類固醇; 細胞毒性藥物; Lupus nephritis; Pathology; Corticosteroid; Cytotoxic drug; |
語 文 | 中文(Chinese) |
中文摘要 | 狼瘡腎炎的臨床症狀變化多端,輕微者可能只有持續不正常的 尿液檢查,但也可能會出現急性腎絲球腎炎症候群、腎病症候群 (nephrotic syndrome) 、快速進行性腎絲球腎炎 (rapidly progressive glomerulonephritis)或慢性腎衰竭。診斷方面端賴尿 液、血清和腎臟超音波等檢查。腎臟病理切片的診斷價值不高,但根據世界 衛生組織 (World Health Organization,簡稱 WHO) 的五大分類以及 「活性度」和「慢性度」的評估,也可以作為狼瘡腎炎的治療指引。狼瘡腎 炎的治療甚具爭議性,藥物治療一般包括以下數種選擇:口服或脈衝式類固 醇、脈衝式類固醇合併口服細胞毒性藥物或脈衝式cyclophosphamide。 從1986至1992年,台大醫院一共治療了39位經病理切片檢查証實之狼 瘡腎炎病人,病人之臨床表現以水腫、高血壓和關節發炎最為常見,大部分 人也有血清學上的異常變化。病理切片結果以WHO第四類居多。治療方面, 半數以上接受兩種或以上的治療方法,而得到顯著療效者共18位。治療的 併發症包括感染和上消化道出血等。總而言之,治療狼瘡腎炎必須按照病人 的病情及/或病理發現選擇適當的治療方法,並隨時監測治療效果與藥物副 作用。 |
英文摘要 | The clinical manifestationof lupus nephritis varies greatly. Patients may have persistent abnormality of urinalysis only, but in more severe cases, acute glomerulonephritis syndrome, nephrotic syndrome, rapidly progressive glomerulonephritis or chronic renal failure predominates. Diagnosis is based on the examination of urine, serum and renal sonography. Although the diagnostic value of renal biopsy is not high, the classification of lupus nephritis according to the World Health Organization (WHO) as well as the grading of both activity and chronicity provide valuable therapetic guide. The treatment of lupus nephritis remains controversial. Medications include oral or pulse steroid, pulse steroid combined with oral cytotoxic agent or pulse cyclophosphamide. From 1986 to 1992,39 patients with biopsy-proved lupus nephritis had been treated at National Taiwan University Hospital. The major clinical presentations of these patients were edema, hypertension and arthritis. Mosts of them had also had serological abnormalities. The most common finding of renal pathology was WHO Class IV. More than half of these patients received combined therapy containing two or more agents and 18 patients had significant improvement. Complication of treatment included infection and upper gastrointestinal bleeding. In summary, treatment should be initiated for patients according to their clinical condition and/or pathologic findings. The therapeutic response as well as the side effect of drug must be monitored periodically. (J Inter Med Taiwan 1997;8:62-69) |
本系統中英文摘要資訊取自各篇刊載內容。